All Stories

  1. Efficacy and Tolerability of Direct-Acting Antivirals for Hepatitis C in Older Adults

    Article • Journal of the American Geriatrics Society, May 2018, Wiley

    Professor Geoffrey M Dusheiko

  2. Serum NGAL can act as an early renal safety biomarker during long-term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B

    Article • Journal of Viral Hepatitis, May 2018, Wiley

    Professor Geoffrey M Dusheiko

  3. HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues

    Article • Journal of Viral Hepatitis, April 2018, Wiley

    Professor Geoffrey M Dusheiko

  4. Current and future directions of management of hepatitis B: steps toward a cure

    Article • Future Virology, February 2018, Future Medicine

    Professor Geoffrey M Dusheiko

  5. The impact of antiviral therapy for hepatitis C on the quality of life: a perspective

    Article • Liver International, January 2017, Wiley

    Professor Geoffrey M Dusheiko

  6. Viral hepatitis

    Article • Hepatology, August 2016, Wiley

    Professor Geoffrey M Dusheiko

  7. Conceptual framework for outcomes research studies of hepatitis C: an analytical review

    Article • Infection and Drug Resistance, May 2016, Dove Medical Press

    PhD Urbano Sbarigia, Professor Geoffrey M Dusheiko